Synthesis of betulin derivatives and the determination of their relative lipophilicities using reversed-phase thin-layer chromatography

Biomedical Chromatography

Volumn 24, Issue 3, 2010, Pages 261-267

  Achrem Achremowicz, Jacek ^a   Kȩpczyńska, Elzbieta ^b   Zylewski, Marek ^b   Janeczko, Zbigniew ^b  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Betulin derivatives; Lipophilicity; RP TLC; Triterpenes

Indexed keywords

SYNTHESIS (CHEMICAL);

ACETATE BUFFERS; BETULIN DERIVATIVE; BUFFER MIXTURES; LINEAR RELATIONSHIPS; LIPOPHILICITY; MOBILE PHASIS; PH VALUE; REFERENCE COMPOUNDS; REVERSED-PHASE THIN-LAYER CHROMATOGRAPHY; TRITERPENES;

THIN LAYER CHROMATOGRAPHY;

30 METHOXY LUP 20(29)EN 3BETA,28 DIOL(30 METHOXYBETULIN); 30 METHOXYBETULIN; ALLOBETULIN; BETULIN; BETULIN 28 ACETATE; BETULIN 3 ACETATE; BETULIN BIS(HEMIGLUTARATE); BETULIN BIS(O HEMIPHTALATE); BETULIN DIACETATE; BETULIN DIBENZOATE; BETULIN DIPROPIONATE; CHOLESTEROL; DIHYDROBETULIN; DIHYDROBETULIN DIACETATE; DIOXANE DERIVATIVE; ESTRADIOL; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; DRUG SYNTHESIS; LIPOPHILICITY; PH; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE LIQUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY;

EID: 76149093197     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1282     Document Type: Article

References (40)

1. Bajda M, Bucki A, Szlȩk J, Szwaczkiewicz M, Świerczek M and Malawska B. Determination of lipophilicity of a-(4-phenylpiperazine) derivatives of N-benzylamides using chromatographic and computational methods. Biomedical Chromatography 2008; 22: 428.
2. Beilstein FK. Beilsteins Handbuch der organischen Chemie, 4. Aufl . die Literatur von 1920-1929 umfassend, Zweites Ergänzungswerk, Vol. 6. Springer: Berlin, 1941-1957.
3. Berthod A. Band broadening inside the chromatographic column: the interest of a liquid stationary phase. Journal of Chromatography A 2006; 1126: 347-356.
4. Biagi G, Recantini M, Barbaro A and Borea P. Lipophilicity estimation of drugs. Process Control and Quality 1997; 10: 129-149.
5. Bureeva S, Andia-Pravdivy J, Symon A, Bichucher A, Moskaleva V, Popenko V, Shpak A, Shvets V, Kozlov L and Kaplun A. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates. Bioorganic and Medicinal Chemistry 2007; 15: 3489-3498.
6. Chowdhury A, Mandal S, Goswami A, Ghosh M, Mandal L, Chakraborty D, Ganguly A, Tripathi G, Mukhopadhyay S, Bandyopadhyay S et al. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy. Molecular Medicine 2003; 9: 26-36.
7. Eckerman C and Ekman R. Comparison of solvents for extraction and crystallisation of betulinol from birch bark waste. Paperi ja Puu - Papper och Trä 1985; 3: 100-106.
8. Fulda S. Betulinic acid for cancer treatment and prevention. International Journal of Molecular Sciences 2008; 9: 1096-1107.
9. Gauthier C, Legault J, Lebrun M, Dufour P and Pichette A. Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents. Bioorganic and Medicinal Chemistry 2006; 14: 6713-6725.
10. Hansch C, Maloney P, Fujita T and Muir R. Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coeffi cients. Nature 1962; 194: 178-180.
11. Hayek EWH, Jordis U, Moche W and Sauter F. A bicentennial of betulin. Phytochemistry 1989; 28: 2229-2242.
12. Hiroya K, Takahashi T, Miura N, Naganuma A and Sakamoto T. Synthesis of betulin derivatives and their protective eff ects against the cytotoxicity of cadmium. Bioorganic and Medicinal Chemistry 2002; 10: 3229-3236.
13. Horobin R, Trapp S and Weissig V. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. Journal of Controlled Release 2007; 121: 125-136.
14. Huguet A, del Carmen Recio M, Máñez S, Giner R and Rìos J. Eff ect of triterpenoids on the infl ammation induced by protein kinase c activators, neuronally acting irritants and other agents. European Journal of Pharmacology 2000; 410: 69-81.
15. Inglot T, Gumieniczek A, Komsta Ł and Kasińska A. LC and principal component analysis in the lipophilicity study of seven angiotensin iI-AT1 receptor antagonists (sartans). Chromatographia 2008; 68: 977-983.
16. Kashiwada Y, Sekiya M, Ikeshiro Y, Fujioka T, Kilgore NR, Wild CT, Allaway GP and Lee KH. 3-o-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents. Bioorganic and Medicinal Chemistry Letters 2004; 14: 5851-5853.
17. Kȩpczyńska E, Obłoza E, Stasiewicz-Urban A, Bojarski J and Pyka A. Lipophilicity of thiobarbiturates determined by TLC. Acta Poloniae Pharmaceutica Drug Research 2007; 164: 295-302.
18. Kvasnica M, Sarek J, Klinotova E, Dzubak P and Hajduch M. Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity. Bioorganic and Medicinal Chemistry 2005; 13: 3447-3454.
19. Lavoie S, Pichette A, Garneau FX, Girard M and Gaudet D. Synthesis of betulin derivatives with solid supported reagents. Synthetic Communications 2001; 31: 1565-1571.
20. Lehn J and Ourisson G. Synthèses dans la série du lupane. Bulletin de la Societe Chimique de France 1962; 1133-1136.
21. Li TS, Wang JX and Zheng XJ. Simple synthesis of allobetulin, 28-oxyallobetulin and related biomarkers from betulin and betulinic acid catalysed by solid acids. Journal of the Chemical Society, Perkin Transactions 1998; 1: 3957-3966.
22. Liu X, Hefesha H, Tanaka H, Scriba G and Fahr A. Lipophilicity measurement of drugs by reversed phase HPLC over wide pH range using an alkaline-resistant silica-based stationary phase, XBridge TM Shield RP. Chemical and Pharmaceutical Bulletin 2008; 56: 1417-1422.
23. Malawska B, Kulig K, Bucki A, Zbek P and Wiȩckowska A. The study of the lipophilicity of-(4-phenylpiperazin-1-yl)-phthalimidobutyramides using chromatographic and computational methods. Biomedical Chromatography 2008; 22: 688-694.
24. Máñez S, Recio MC, Giner RM and Rìos JL. Eff ect of selected triterpenoids on chronic dermal infl ammation. European Journal of Pharmacology 1997; 334: 103-105.
25. Mannhold R. Molecular Drug Properties. Wiley-VCH: Weinheim 2008.
26. Miura N, Matsumoto Y, Miyairi S, Nishiyama S and Naganuma A. Protective effects of triterpene compounds against the cytotoxicity of cadmium in HepG2 cells. Molecular Pharmacology 1999; 56: 1324-1328.
27. Mukherjee R, Jaggi M, Siddiqui MJ, Srivastava SK, Rajendran P, Vardhan A and Burman AC. Synthesis and cytotoxic activity of 3-o-acyl/3-hydrazine/ 2-bromo/20,29-dibromo betulinic acid derivatives. Bioorganic and Medicinal Chemistry Letters 2004; 14: 4087-4091.
28. Musilek K, Jampilek J, Dohnal J, Jun D, Gunn-Moore F, Dolezal M and Kuca K. RP-HPLC determination of the lipophilicity of bispyridinium reactivators of acetylcholinesterase bearing a but-2-ene connecting linker. Analytical and Bioanalytical Chemistry 2008; 391: 367-372.
29. Musiol R, Tabak D, Niedbala H, Podeszwa B, Jampilek J, Kralova K, Dohnal J, Finster J, Mencel A and Polanski J. Investigating biological activity spectrum for novel quinoline analogues 2: hydroxyquinolinecarboxamides with photosynthesis-inhibiting activity. Bioorganic and Medicinal Chemistry 2008; 16: 4490-4499.
30. Oh SH, Choi JE and Lim SC. Protection of betulin against cadmiuminduced apoptosis in hepatoma cells. Toxicology 2006; 220: 1-12.
31. Perišić-Janjić N, Djaković-Sekulić T and Penov-Gaši K. HPTLC chromatography of androstene derivates. Application of normal phase thin-layer chromatographic retention data in QSAR studies. Steroids 2005; 70: 137-144.
32. Pliška V, Testa B and van de Waterbeemb H. Lipophilicity in Drug Action and Toxicology. VCH: Weinheim 1996.
33. Pramanick S, Mandal S, Mukhopadhyay S and Jha S. Allylic hydroxylation through acid catalysed epoxy ring opening of betulinic acid derivatives. Synthetic Communications 2005; 35: 2143-2148.
34. Pyka A and Babuska M. Lipophilicity of selected steroid compounds. I. Investigations on RP18W stationary phase by RP-HPTLC. Journal of Liquid Chromatography & Related Technologies 2006; 29: 1891-1903.
35. Sami A, Taru M, Salme K and Jari YK. Pharmacological properties of the ubiquitous natural product betulin. European Journal of Pharmaceutical Sciences 2006; 29: 1-13.
36. Sarbu C, Kuhajda K and Kevresan S. Evaluation of the lipophilicity of bile acids and their derivatives by thin-layer chromatography and principal component analysis. Journal of Chromatography A 2001; 917: 361-366.
37. Sun IC, Shen JK, Wang HK, Cosentino LM and Lee KH. Anti-aids agents. 32. Synthesis and anti-hiv activity of betulin derivatives. Bioorganic and Medicinal Chemistry Letters 1998; 8: 1267-1272.
38. Sztanke K, Tuzimski T, Rzymowska J, Pasternak K and Kandefer- Szerszeń M. Synthesis, determination of the lipophilicity, anticancer and anti-microbial properties of some fused 1, 2, 4-triazole derivatives. European Journal of Medicinal Chemistry 2008; 43: 404-419. Thibeault D, Gauthier C, Legault J, Bouchard J, Dufour P and Pichette A. Synthesis and structure-activity relationship study of cytotoxic germanicane-and lupane-type 3ß-O-monodesmosidic saponins starting from betulin. Bioorganic and Medicinal Chemistry 2007; 15: 6144-6157.
39. Westover E and Covey D. Synthesis of ent-25-hydroxycholesterol. Steroids 2006; 71: 484-488.
40. Ziegler HL, Franzyk H, Sairafi anpour M, Tabatabai M, Tehrani MD, Bagherzadeh K, Hägerstrand H, Staerk D and Jaroszewski JW. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: structure-activity relationships for betulinic acid analogues. Bioorganic and Medicinal Chemistry 2004; 12: 119-127.